检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:屈雅丽[1] QU Yali(Zhengzhou Orthopaedics Hospital,Zhengzhou 450000,Henan,China)
出 处:《实用中医内科杂志》2020年第12期50-52,共3页Journal of Practical Traditional Chinese Internal Medicine
基 金:河南省高等学校重点科研计划(17A330054)。
摘 要:目的探讨加减桃核承气颗粒联合甘露醇对胫腓骨双骨折患者术后康复及不良反应的影响。方法按照随机数表法将2017年6月-2018年6月期间于医院接受手术治疗的80例胫腓骨双骨折患者分为对照组和观察组,对照组患者甘露醇,观察组患者使用加减桃核承气颗粒联合甘露醇进行治疗。结果观察组治疗后患者术后患肢最大周径、手术前后周径差、肿胀率及VAS评分均比对照组低,差异具有统计学意义(P <0.05);观察组与对照组相比,并未明增加不良反应,差异无统计学意义(P> 0.05)。结论对胫腓骨双骨折患者实施加减桃核承气颗粒联合甘露醇治疗不仅可以有效加快患者康复进程,减轻疼痛程度,且在治疗过程中并未明增加不良反应,安全性较高,值得临床推广应用。Objective To investigate the effect of Modified Taohe Chengqi Granule combined with mannitol on postoperative rehabilitation and adverse reactions in patients with tibiofibular double fracture. Methods Eighty patients with fractures of tibial and fibula treated in our hospital in from June 2017 to June 2018 were divided into control group and observation group according to random number table method. The patients in the control group were treated with mannitol,and those in the observation group were treated by Modified Taohe Chengqi Granule and mannitol. Results After treatment,the maximum circumference of the affected limbs,the circumference difference before and after operation,the swelling rate and VAS score in the observation group were significantly lower than those in the control group (P < 0. 05),but there was no significant difference of the adverse reactions between the observation group and the control group (P > 0. 05). Conclusion The combination of Modified Taohe Chengqi Granule and mannitol can effectively speed up the rehabilitation process and relieve the pain,and do not increase the adverse reactions. The safety is high,and so it is worthy of popularizing and applying in clinic.
关 键 词:加减桃核承气颗粒 甘露醇 胫腓骨双骨折 术后康复 不良反应
分 类 号:R274.1[医药卫生—中医骨伤科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.38